Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((aminoglycosides)):

Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults. LeBras M et al. Neurocrit Care. (2016)

Do we still need the aminoglycosides? Durante-Mangoni E et al. Int J Antimicrob Agents. (2009)

Aminoglycosides: how should we use them in the 21st century? Jackson J et al. Curr Opin Infect Dis. (2013)

Search results

Items: 1 to 20 of 156542

1.

What is the recommended amikacin dosing for cystic fibrosis patients with acute pulmonary exacerbations?

Thirion DJG, Pasche V, Marsot A.

Pediatr Pulmonol. 2019 Jul 16. doi: 10.1002/ppul.24453. [Epub ahead of print] No abstract available.

PMID:
31313524
2.

Reply to Nikaido: The pyruvate cycle provides respiratory energy and potentiates aminoglycosides to kill multidrug-resistant bacteria.

Li H, Zhang TT, Chen ZG, Ye JZ, Zhang S, Yang J, Peng XX, Peng B.

Proc Natl Acad Sci U S A. 2019 Jul 16. pii: 201812316. doi: 10.1073/pnas.1812316115. [Epub ahead of print] No abstract available.

PMID:
31311875
3.

P cycle cannot be a general mechanism for energy production, and it does not sensitize bacteria toward aminoglycosides.

Nikaido H.

Proc Natl Acad Sci U S A. 2019 Jul 16. pii: 201811810. doi: 10.1073/pnas.1811810115. [Epub ahead of print] No abstract available.

PMID:
31311872
4.

Gentamicin vestibulotoxicity with modern systemic dosing regimens: a prospective study using video-oculography.

Smyth D, Mossman S, Weatherall M, Jolliffe E, Joshi P, Taylor J, Thorne K, Watson E, Leadbetter R, Mossman B, Moss T, Todd N, Schneider E.

Acta Otolaryngol. 2019 Jul 16:1-9. doi: 10.1080/00016489.2019.1637935. [Epub ahead of print]

PMID:
31311369
5.

Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli.

Mancini S, Marchesi M, Imkamp F, Wagner K, Keller PM, Quiblier C, Bodendoerfer E, Courvalin P, Böttger EC.

EBioMedicine. 2019 Jul 12. pii: S2352-3964(19)30455-4. doi: 10.1016/j.ebiom.2019.07.020. [Epub ahead of print]

PMID:
31307955
Free Article
6.

Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates.

El-Khier MARANTA.

Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190103.

PMID:
31307186
7.

Serial quantification of urinary protein biomarkers to predict drug-induced acute kidney injury.

Da Y, Akalya K, Murali T, Vathsala A, Tan CS, Low S, Lim HN, Teo BW, Lau T, Ong L, Chua HR.

Curr Drug Metab. 2019 Jul 11. doi: 10.2174/1389200220666190711114504. [Epub ahead of print]

PMID:
31296157
8.

Whole-genome analysis of EC129, an NDM-5-, CTX-M-14-, OXA-10-, and mcr-1-co-producing Escherichia coli ST167 strain isolated from Japan.

Nukui Y, Ayibieke A, Taniguchi M, Aiso Y, Shibuya Y, Sonobe K, Nakajima J, Kanehira S, Hadano Y, Tohda S, Koike R, Saito R.

J Glob Antimicrob Resist. 2019 Jul 8. pii: S2213-7165(19)30167-5. doi: 10.1016/j.jgar.2019.07.001. [Epub ahead of print]

PMID:
31295582
9.

Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model.

Maiden MM, Zachos MP, Waters CM.

Front Microbiol. 2019 Jun 20;10:1348. doi: 10.3389/fmicb.2019.01348. eCollection 2019.

PMID:
31293530
Free PMC Article
10.

Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).

Kateete DP, Kamulegeya R, Kigozi E, Katabazi FA, Lukoye D, Sebit SI, Abdi H, Arube P, Kasule GW, Musisi K, Dlamini MG, Khumalo D, Joloba ML.

BMC Pulm Med. 2019 Jul 10;19(1):124. doi: 10.1186/s12890-019-0891-x.

PMID:
31291943
Free Article
11.

Systemic allergic dermatitis due to gentamicin.

Corazza M, Forconi R, Toni G, Scuderi V, Mantovani L, Borghi A.

Contact Dermatitis. 2019 Jul 10. doi: 10.1111/cod.13352. [Epub ahead of print]

PMID:
31291007
12.

Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients.

Abo Basha J, Kiel M, Görlich D, Schütte-Nütgen K, Witten A, Pavenstädt H, Kahl BC, Dobrindt U, Reuter S.

J Clin Med. 2019 Jul 7;8(7). pii: E988. doi: 10.3390/jcm8070988.

13.

Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).

Campofelice A, Lentini L, Di Leonardo A, Melfi R, Tutone M, Pace A, Pibiri I.

Int J Mol Sci. 2019 Jul 6;20(13). pii: E3329. doi: 10.3390/ijms20133329. Review.

14.

Ribosomal RNA-Aminoglycoside Hygromycin B Interaction Energy Calculation within a DFT Framework.

Bezerra KS, Fulco UL, Esmaile SC, Lima Neto JX, Machado LD, Freire VN, Albuquerque EL, Oliveira JIN.

J Phys Chem B. 2019 Jul 8. doi: 10.1021/acs.jpcb.9b04468. [Epub ahead of print]

PMID:
31283875
15.

Genome and plasmid context of two rmtG-carrying Enterobacter hormaechei isolated from urinary tract infections in Brazil.

Martins ER, Bueno MFC, Francisco GR, Casella T, de Oliveira Garcia D, Cerdeira LT, Gerber AL, de Almeida LGP, Lincopan N, de Vasconcelos ATR, Nogueira MCL.

J Glob Antimicrob Resist. 2019 Jul 3. pii: S2213-7165(19)30164-X. doi: 10.1016/j.jgar.2019.06.020. [Epub ahead of print]

PMID:
31279132
16.

Natural Alkaloid Berberine Activity against Pseudomonas aeruginosa MexXY-Mediated Aminoglycoside Resistance: In Silico and in Vitro Studies.

Laudadio E, Cedraro N, Mangiaterra G, Citterio B, Mobbili G, Minnelli C, Bizzaro D, Biavasco F, Galeazzi R.

J Nat Prod. 2019 Jul 5. doi: 10.1021/acs.jnatprod.9b00317. [Epub ahead of print]

PMID:
31274312
17.

Antimicrobial-resistance in Escherichia coli isolatedfrom wild pheasants (Phasianus colchicus).

Holko I, Doležalová M, Pavlíčková S, Gal R, Valenta T, Holkova T.

Vet Ital. 2019 Jun 30;55(2):169-172. doi: 10.12834/VetIt.887.4400.3.

18.
19.

Chronic treatment with hydroalcoholic extract of Plathymenia reticulata promotes islet hyperplasia and improves glycemic control in diabetic rats.

Magalhães FO, Uber-Bucek E, Ceron PIB, Name TF, Coelho HE, Barbosa CHG, Carvalho T, Groppo M.

Einstein (Sao Paulo). 2019 Jul 1;17(3):eAO4635. doi: 10.31744/einstein_journal/2019AO4635. English, Portuguese.

20.

L-Tryptophan represses persister formation via inhibiting bacterial motility and promoting antibiotics absorption.

Li Y, Liu B, Guo J, Cong H, He S, Zhou H, Zhu F, Wang Q, Zhang L.

Future Microbiol. 2019 Jun;14:757-771. doi: 10.2217/fmb-2019-0051. Epub 2019 Jul 4.

PMID:
31271063

Supplemental Content

Loading ...
Support Center